安杰思收盘上涨1.83%，滚动市盈率17.72倍，总市值52.61亿元

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Anjies Medical Technology Co., Ltd., which has a closing price of 64.97 yuan and a rolling PE ratio of 17.72, marking a new low in 12 days [1] - The company operates in the medical device industry, which has an average PE ratio of 51.00 and a median of 37.03, placing Anjies at the 41st position in the industry ranking [1][2] - As of the first quarter of 2025, 11 institutions hold shares in Anjies, with a total of 17.73 million shares valued at 1.26 billion yuan [1] Group 2 - Anjies specializes in the research, production, and sales of endoscopic minimally invasive diagnostic and therapeutic devices, with key products including GI, EMR/ESD, and ERCP diagnostic series [1] - The company has received seven significant government honors, including recognition as a "Zhejiang Provincial Enterprise Technology Center" and "Zhejiang Provincial High-Growth Biopharmaceutical Enterprise" [1] - In the latest financial report for the first quarter of 2025, Anjies reported revenue of 129 million yuan, a year-on-year increase of 15.27%, and a net profit of 56.25 million yuan, reflecting a year-on-year growth of 6.57% with a gross margin of 70.68% [1]